Viewing Study NCT06505291



Ignite Creation Date: 2024-10-26 @ 3:35 PM
Last Modification Date: 2024-10-26 @ 3:35 PM
Study NCT ID: NCT06505291
Status: COMPLETED
Last Update Posted: None
First Post: 2024-06-25

Brief Title: Long-term Management of Patients With Ruptured HCC
Sponsor: None
Organization: None

Study Overview

Official Title: Long-term Management of Patients With Ruptured HCC
Status: COMPLETED
Status Verified Date: 2024-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The main objective of this work is to evaluate the prevalence and results of specific management of HCC after spontaneous rupture since the arrival of sorafenib in 2008
Detailed Description: Retrospective observational multicenter study over the period from January 2008 to April 2024

Cases had to be 18 years or older They were identified by two different methodologies adapted to the 4 participating centers In particular a request for ICD10 C220 CHC codes associated with K661 hemoperitoneum was carried out by the medical information departments DIM of the Caen University Hospital and the Avicenne hospital Secondly the automated keyword selection tools Cohort 360 and i2b2 were used at the La Pitié Salpetrière and Paul Brousse hospital centers to identify the terms CHC and ruptured in the computerized patient files Secondarily duplicates and coding errors were excluded

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None